$1.69 Billion is the total value of Sofinnova Investments, Inc.'s 53 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HZNP | New | Horizon Therapeutics PLC | $47,019,087 | – | 413,173 | +100.0% | 2.79% | – |
VRTX | New | Vertex Pharmaceuticals Inc | $45,335,283 | – | 156,989 | +100.0% | 2.69% | – |
ALNY | New | Alnylam Pharmaceuticals Inccall | $23,765,000 | – | 100,000 | +100.0% | 1.41% | – |
ALGN | New | Align Technology Inc | $17,525,790 | – | 83,100 | +100.0% | 1.04% | – |
ALNY | New | Alnylam Pharmaceuticals Inc | $13,414,867 | – | 56,448 | +100.0% | 0.80% | – |
KURA | New | Kura Oncology Inc | $7,366,092 | – | 593,561 | +100.0% | 0.44% | – |
CYTK | New | Cytokinetics Inccall | $4,582,000 | – | 100,000 | +100.0% | 0.27% | – |
AGEN | New | Agenus Inccall | $3,040,800 | – | 1,267,000 | +100.0% | 0.18% | – |
CTIC | New | CTI Biopharma Corpcall | $2,464,100 | – | 410,000 | +100.0% | 0.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Natera, Inc. | 23 | Q3 2023 | 20.5% |
Ascendis Pharma A/S | 23 | Q3 2023 | 27.9% |
NuCana plc | 23 | Q3 2023 | 15.2% |
Synlogic Inc. (fmrly Mirna) | 22 | Q2 2023 | 0.9% |
Y-mAbs Therapeutics, Inc. | 21 | Q3 2023 | 6.5% |
ObsEva SA | 20 | Q4 2022 | 11.0% |
Nucana PLC | 19 | Q3 2023 | 9.7% |
SYNDAX PHARMACEUTICALS INC | 19 | Q3 2023 | 2.2% |
PDS Biotechnology Corporation | 19 | Q3 2023 | 0.1% |
Karuna Therapeutics, Inc. | 18 | Q3 2023 | 27.1% |
View Sofinnova Investments, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
OTONOMY, INC.Sold out | February 14, 2022 | 0 | 0.0% |
View Sofinnova Investments, Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
SC 13G/A | 2022-02-14 |
View Sofinnova Investments, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.